Latest filing published 22 Oct 2021 for Annexin Pharmaceuticals AB (publ), €9,370. Read the official filing
No signal scores available.
All filings by Henrik Palm on record concern Annexin Pharmaceuticals AB (publ). Altogether 2 filings, all relating to 22 October 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 27 October 2021: a transaction of €9,370, in Annexin Pharmaceuticals AB (publ). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration